BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17023732)

  • 1. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.
    Christie JD; Robinson N; Ware LB; Plotnick M; De Andrade J; Lama V; Milstone A; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM
    Am J Respir Crit Care Med; 2007 Jan; 175(1):69-74. PubMed ID: 17023732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
    Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
    Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construct validity of the definition of primary graft dysfunction after lung transplantation.
    Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V; Palmer S; Orens J; Weinacker A; Crespo M; Demissie E; Kimmel SE; Kawut SM
    J Heart Lung Transplant; 2010 Nov; 29(11):1231-9. PubMed ID: 20655249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.
    Ware LB; Matthay MA; Parsons PE; Thompson BT; Januzzi JL; Eisner MD;
    Crit Care Med; 2007 Aug; 35(8):1821-8. PubMed ID: 17667242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
    Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z
    Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
    Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
    J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
    Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
    Cantu E; Suzuki Y; Diamond JM; Ellis J; Tiwari J; Beduhn B; Nellen JR; Shah R; Meyer NJ; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Ware LB; Wang F; Feng R; Christie JD;
    Am J Transplant; 2016 Mar; 16(3):833-40. PubMed ID: 26663441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of acute cellular rejection on coagulation and fibrinolysis biomarkers within the immediate post-operative period in pediatric liver transplantation.
    Mimuro J; Mizuta K; Kawano Y; Hishikawa S; Hamano A; Kashiwakura Y; Ishiwata A; Ohmori T; Madoiwa S; Kawarasaki H; Sakata Y
    Pediatr Transplant; 2010 May; 14(3):369-76. PubMed ID: 19793340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
    Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
    Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
    Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
    Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation.
    Covarrubias M; Ware LB; Kawut SM; De Andrade J; Milstone A; Weinacker A; Orens J; Lama V; Wille K; Bellamy S; Shah C; Demissie E; Christie JD;
    Am J Transplant; 2007 Nov; 7(11):2573-8. PubMed ID: 17908278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
    Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
    Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
    Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
    J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.
    Diamond JM; Meyer NJ; Feng R; Rushefski M; Lederer DJ; Kawut SM; Lee JC; Cantu E; Shah RJ; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Weill D; Arcasoy S; Shah PD; Belperio JA; Wilkes D; Ware LB; Palmer SM; Christie JD;
    Am J Respir Crit Care Med; 2012 Sep; 186(6):546-52. PubMed ID: 22822025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
    Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
    Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.